Indomethacin Suppositories

Indomethacin Suppositories

Form: Suppositories

Strength: 25 mg, 50 mg

Reference Brands: Indocin(US & EU)

Category: Analgesic

Indomethacin suppositories are approved in the EU and US for short-term management of pain and inflammation, particularly in patients who cannot take oral medications. In the EU, they are regulated by EMA and require dossiers demonstrating safety, efficacy, and quality standards. In the US, FDA approval is based on extensive clinical data, with biosimilarity assessments and pharmacovigilance. Both regions require detailed dossiers for initial approval and continuous safety monitoring. For regulatory support, dossier preparation, and registration assistance, visit PharmaTradz. We ensure smooth market access for indomethacin suppositories, aligning with European and US regulatory standards for safe, effective anti-inflammatory therapy.

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

Dexketoprofen + Tramadol tablets

Strength: 25 mg dexketoprofen + 37.5 mg tramadol

Form: Tablets

Reference Brands: Enantyum(EU)

View Details Get Enquiry
Paracetamol + Codeine tablets

Strength: 300 mg paracetamol + 30 mg codeine; 300 mg + 60 mg

Form: Tablets

Reference Brands: Tylenol with Codeine(US)

View Details Get Enquiry
Aceclofenac + Paracetamol tablets

Strength: 100 mg Aceclofenac + 325 mg Paracetamol

Form: Tablets

Reference Brands: Generic formulations marketed under different names

View Details Get Enquiry
Tramadol + Paracetamol tablets

Strength: 37.5 mg tramadol + 325 mg paracetamol; 75 mg + 650 mg

Form: Oral Tablets

Reference Brands: Ultracet(US); Tramacet(EU)

View Details Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.